Dergiler / Diagnostic and Interventional Radiology / 2021 / Cilt: 27 - Sayı: 3

Percutaneous radiofrequency ablation for hepatic tumors: factors affecting baseline impedance

Sayfa
386–393
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Positioning pads on the back lowers the baseline impedance and can shorten the first roll-off time, ultimately resulting in reduced total ablation time.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:PURPOSE We aimed to evaluate factors that affect baseline impedance of percutaneous radiofrequency ablation.METHODSIn this retrospective study, we analyzed 51 patients with 55 hepatic tumors from November 2015 until April 2018.
📊
Temel Bulgular & Veri:We measured the baseline impedance nine times with three adjustable tip sizes (2 cm, 2.5 cm, 3 cm) and three different pad locations (two pads attached on the thigh, four on the thigh, two on the back).
💡
Sonuç & Katkı:Positioning pads on the back lowers the baseline impedance and can shorten the first roll-off time, ultimately resulting in reduced total ablation time.
🔬Tür:Araştırma Makalesi
📍Kapsam:2015 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

PURPOSE We aimed to evaluate factors that affect baseline impedance of percutaneous radiofrequency ablation.METHODSIn this retrospective study, we analyzed 51 patients with 55 hepatic tumors from November 2015 until April 2018. We measured the baseline impedance nine times with three adjustable tip sizes (2 cm, 2.5 cm, 3 cm) and three different pad locations (two pads attached on the thigh, four on the thigh, two on the back). The first roll-off time was measured with two grounding pads attached on the back. Body mass index, cirrhotic or non-cirrhotic liver parenchyma, previous procedure, tumor location, artificial ascites, active tip size, and the pad location were evaluated as potential factors affecting baseline impedance using the Mann–Whitney U test, t-test and analysis of variance test.RESULTSComplete radiofrequency ablation was achieved in 51 patients. Body mass index (p = 0.897), cirrhotic or non-cirrhotic liver parenchyma (p = 0.767), previous procedure (p = 0.957), tumor location (p = 0.906), and artificial ascites (p = 0.882) did not significantly affect baseline impedance. Grounding pads located on the back showed the lowest baseline impedance (p < 0.001). Increase in active tip size showed gradual decrease in baseline impedance (p = 0.016).CONCLUSIONThe factors affecting baseline impedance were the pad location and the tip size. Positioning pads on the back lowers the baseline impedance and can shorten the first roll-off time, ultimately resulting in reduced total ablation time.

🔖

Bu Makaleye Atıf Yap

HWANG, S., WOOK-SEO, J., LEE, B. H., BAE, S. H., LEE, Y. K. (2021). Percutaneous radiofrequency ablation for hepatic tumors: factors affecting baseline impedance. Diagnostic and Interventional Radiology, Cilt: 27 - Sayı: 3, 386–393. https://ajindex.com/articles/350092

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics. CA Cancer J Clin 2015; 65:87–108. [Crossref] 2. Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 2016; 150:835–853. [Crossref] 3. Li Z, Zhang K, Lin SM, et al. Radiofrequency ablation combined with percutaneous ethanol injection for hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia 2017; 33:237–246. [Crossref] 4. European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2018; 69:182–236. 5. Okuma T, Matsuoka T, Yamamoto A, et al. Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution. Cardiovasc Intervent Radiol 2010; 33:787–793. [Crossref] 6. Nouso K, Oonishi A, Wakuta A, Kariyama K. Modified radiofrequency ablation for the treatment of hepatocellular carcinoma. Hepatol Res 2016; 46:1158–1161. [Crossref] 7. Haemmerich D, Schutt DJ. Sequential activation of multiple grounding pads reduces skin heating during radiofrequency tumor ablation. Int J Hyperthermia 2007; 23:555–566. [Crossref] 8. Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Shiozaki H. Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. AJR Am J Roentgenol 2004; 182:1224–1226. [Crossref] 9. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis—part I: review of principles and methods. Clin Nutr 2004; 23:1226–1243. [Crossref] 10. Rhim H, Lim HK. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites. Abdom Imaging 2009; 34:371–380. [Crossref] 11. Laeseke PF, Sampson LA, Brace CL, Winter TC, 3rd, Fine JP, Lee FT, Jr. Unintended thermal injuries from radiofrequency ablation: protection with 5% dextrose in water. AJR Am J Roentgenol 2006; 186:S249–254. [Crossref] 12. Rathke H, Hamm B, Guttler F, et al. Comparison of four radiofrequency ablation systems at two target volumes in an ex vivo bovine liver model. Diagn Interv Radiol 2014; 20:251–258. [Crossref]